Johnny Nacilla MD in Cullman, Alabama

Home Alabama Cullman

Johnny Nacilla MD has Medical Oncology as his primary medical specialty. Their primary office is: 1750 Al Hwy 157 in Cullman, Alabama. They attended Sorry, his university is not listed and graduated in 1982 (around 43 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Johnny Q Nacilla MD Office Phone and Directions

Johnny Nacilla MD
1750 Al Hwy 157
Cullman, Alabama 35058
256-255-2500

Patient Ratings
Please rate your experience with Johnny Nacilla MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 256-255-2500

Enter a starting address:

Healthcare Info for Johnny Nacilla MD

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1982
The Primary Medical Specialty for Johnny Nacilla MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 43
PAC (PECOS ID)#: 7911965785
NPI #: 1346261526
NPI Created On: 07/22/2006
NPI Last Updated Listed as: 04/22/2011
Primary Taxonomy Code: 174400000X
License Number:
00020069
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Chinese.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Bone marrow biopsy
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of drug or substance into a vein for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
Irrigation of implanted venous access drug delivery device
Therapeutic removal of whole blood to correct blood level imbalance
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787549421

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Interventional Solutions

Name of Drug #1: Certus 140

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135293

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135295

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135297

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135299

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788135301

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799852203

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE HEME

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE CDX

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONFOCUS

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONONE LIQUID CDX

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545253

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 782545255

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry